- The Market Entry Playbook From 16 Years at J&J, Philips & Becton Dickinson | Rafael de Matos Leite
Rafael de Matos Leite has run $150M+ P&Ls at J&J, Philips and BD. He explains how to fix a stalled MedTech product and pick the right markets first.

- Addressing the $900M Human Error in Vascular Access | Rhodel Dacanay, CEO of Nevent
Nevent CEO Rhodel Dacanay on the safety sheath that stops retained guidewires: why the error persists, the FDA route, and his $3M Series A.

- Tackling Obesity with a Food-based Gastric Balloon | Kristel de Ridder, Revividal
Revividal CEO Kristel de Ridder on a swallowable, food-based gastric balloon for weight loss: who it's for, how it compares to GLP-1s, and the road to market.

- The PE Playbook: 4 MedTech Companies, 4 Exits | Michael Bencak, 4x MedTech CEO
The PE Playbook: 4 MedTech Companies, 4 Exits | Michael Bencak, 4x MedTech CEO

- Breast Cancer Screening Without Radiation | Alexander Antrobus, Zedsen
Mammography has been the standard for breast cancer screening for decades, but is still struggles where the need is growing. Younger women with dense breast tissue are facing unreliable results, since fibroglandular tissue can mask a cancer entirely. Alexander Antrobus' device uses impedance sensing

- Building the Commercial Engine Behind a $1.75B Exit | Jose de la Cortina, Acandis
Building the Commercial Engine Behind a $1.75B Exit | Jose de la Cortina, Acandis

- Inside Catheter, Balloon and ePTFE Manufacturing | Robert Murray III, Aptyx
Inside Catheter, Balloon and ePTFE Manufacturing | Robert Murray III, Aptyx

- Insights From an Investor With 20+ MedTech Board Seats | Irit Yaniv, Almeda Ventures
What does a MedTech investor, board chair, and former CEO actually look for when evaluating a company? What makes them say no before the meeting is over? In this episode of the GS MedTech Podcast, we sat down with Dr. Irit Yaniv - a MedTech veteran who has sat on almost 20 boards and has held over 1

- Building a Deep Tech Company As a CEO, Not a Scientist | Maria Leiloglou, Enacuity
Dr. Maria Leiloglou spent years researching imaging technology for surgery before co-founding Enacuity - a software-only hyperspectral imaging solution that allows clinicians to see critical information about tissue oxygenation and blood perfusion with standard cameras. But building a company meant

- Automating Oxygen Therapy | Marie-Louise Little, O2matic
Oxygen therapy has been delivered the same way for over a century - manually, inconsistently, and wrong roughly 50% of the time for critical patients. In this episode, we sat down with Marie-Louise Little, CEO of O2matic, to explore why that's finally changing. Marie-Louise brings a rare dual perspe
